B. Lebouché

J. Singer, V. Martel-Laferrière, C. Tremblay, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Plasma Levels of C-Type Lectin REG3α and Gut Damage in People With Human Immunodeficiency Virus Study, the Canadian Cohort of HIV+ Slow Progressors, the Canadian HIV and Aging Cohort Groups

J. Routy, I. Kema, S. Isnard, 2019 .

Cannabis Consumption in People Living with HIV: Reasons for Use, Secondary Effects, and Opportunities for Health Education.

J. Routy, M. Brouillette, Sara J. Abdallah, 2019, Cannabis and cannabinoid research.

The hepatitis C virus cascade of care in a Quebec provincial prison: a retrospective cohort study.

G. Sebastiani, J. Cox, M. Klein, 2019, CMAJ open.

Nasal Nitric Oxide Levels in HIV Infection: A Cross-Sectional Study

L. Lands, J. Routy, A. Shapiro, 2018, AIDS research and treatment.

Barriers and facilitators related to HCV treatment uptake among HIV coinfected populations in Canada: Patient and treatment provider perceptions

M. Klein, B. Lebouché, K. Engler, 2021, Canadian liver journal.

Challenges of Patient Engagement in an HIV Clinical Research Program: A Qualitative Analysis of Stakeholder Accounts

B. Lebouché, K. Engler, D. Lessard, 2020, Journal of patient experience.

Feasibility of a Platform Trial Design for the Development of Mobile Health Applications: A Review.

B. Lebouché, K. Engler, T. Schuster, 2022, Telemedicine journal and e-health : the official journal of the American Telemedicine Association.

Use of Smoking Cessation Aids in a Convenience Sample of PLHIV in a Canadian Tertiary Care Clinic

J. Routy, M. Brouillette, C. Costiniuk, 2019, The Open AIDS Journal.

Use of HIV pre-exposure prophylaxis among urban Canadian gay, bisexual and other men who have sex with men: a cross-sectional analysis of the Engage cohort study

E. Moodie, T. Hart, C. Tremblay, 2021, CMAJ open.

Developing a patient-reported outcome measure for HIV care on perceived barriers to antiretroviral adherence: assessing the needs of HIV clinicians through qualitative analysis

F. Raffi, B. Spire, L. Wong, 2018, Quality of Life Research.

Experiences of Migrant People Living with HIV in a Multidisciplinary HIV Care Setting with Rapid B/F/TAF Initiation and Cost-Covered Treatment: The ‘ASAP’ Study

J. Routy, G. Sebastiani, I. Vedel, 2022, Journal of personalized medicine.

HLA-F on HLA-Null 721.221 Cells Activates Primary NK Cells Expressing the Activating Killer Ig-like Receptor KIR3DS1

D. Geraghty, J. Bruneau, B. Lebouché, 2018, The Journal of Immunology.

Plasma levels of C-type lectin REG3α and gut damage in people with HIV.

C. Tremblay, J. Routy, P. Lakatos, 2019, The Journal of infectious diseases.

Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus

J. Milic, G. Sebastiani, G. Guaraldi, 2020, Clinical Infectious Diseases.

Patient profiles as organizing HIV clinicians’ ART adherence management: a qualitative analysis

F. Raffi, B. Spire, L. Wong, 2018, AIDS care.

Impact of extended-release niacin on immune activation in HIV-infected immunological non-responders on effective antiretroviral therapy

J. Singer, J. Routy, M. Brouillette, 2020, HIV research & clinical practice.

The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection

C. Tremblay, J. Routy, Réjean Thomas, 2016, AIDS.

New directions in HIV healthcare

B. Lebouché, M. Potter, 2011, Expert review of anti-infective therapy.

New directions in HIV

B. Lebouché, M. Potter, 2011 .

The Relationship between Visceral Adiposity and Nonalcoholic Fatty Liver Disease Diagnosed by Controlled Attenuation Parameter in People with HIV: A Pilot Study

J. Routy, G. Sebastiani, G. Guaraldi, 2022, Diagnostics.

Prevalence, predictors and severity of lean non-alcoholic fatty liver disease in HIV-infected patients.

J. Milic, G. Sebastiani, G. Guaraldi, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Telehealth and COVID-19 Pandemic: An Overview of the Telehealth Use, Advantages, Challenges, and Opportunities during COVID-19 Pandemic

M. Pomey, B. Lebouché, Khayreddine Bouabida, 2022, Healthcare.

Cytomegalovirus Seropositivity Is Associated With Increased Microbial Translocation in People Living With Human Immunodeficiency Virus and Uninfected Controls

C. Tremblay, C. Chartrand-Lefebvre, J. Routy, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Determinants of SARS-CoV-2 vaccine willingness among people incarcerated in 3 Canadian federal prisons: a cross-sectional study

S. MacDonald, B. Lebouché, Blake Linthwaite, 2022, CMAJ open.

Brief Report: It's Time to Embed Health-Related Quality of Life Across all Steps of the HIV Care Cascade

B. Lebouché, D. Lessard, K. Dubé, 2022, Journal of acquired immune deficiency syndromes.

CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection

C. Tremblay, C. Chartrand-Lefebvre, J. Routy, 2019, Front. Immunol..

CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection

C. Tremblay, C. Chartrand-Lefebvre, J. Routy, 2019, Front. Immunol..

Development of a Prototype for a Bilingual Patient-Reported Outcome Measure of the Important Health Aspects of Quality of Life in People Living with HIV: The Preference Based HIV Index (PB-HIV)

L. Fellows, N. Mayo, M. Brouillette, 2022, Journal of personalized medicine.

Circulating (1→3)-β-D-glucan Is Associated With Immune Activation During Human Immunodeficiency Virus Infection

C. Tremblay, C. Chartrand-Lefebvre, J. Routy, 2020 .

Circulating (1→3)-β-D-Glucan is associated with immune activation during HIV infection.

V. Martel-Laferrière, C. Tremblay, C. Chartrand-Lefebvre, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Barriers to antiretroviral therapy adherence in developed countries: a qualitative synthesis to develop a conceptual framework for a new patient-reported outcome measure

B. Lebouché, K. Engler, D. Lessard, 2018, AIDS care.

Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody‐dependent (AD) NK cell activation and ADCC

J. Bruneau, B. Lebouché, N. Bernard, 2019, Journal of leukocyte biology.

Patient and Physician Preferences for Regimen Attributes for the Treatment of HIV in the United States and Canada

H. Gelhorn, B. Lebouché, E. Arthurs, 2022, Journal of personalized medicine.

A review of HIV-specific patient-reported measures of perceived barriers to antiretroviral therapy adherence: what themes are they covering?

Sara Ahmed, B. Lebouché, K. Engler, 2019, Journal of Patient-Reported Outcomes.

Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.

C. Tremblay, J. Routy, D. Radzioch, 2015, The Journal of infectious diseases.

Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028)

A. Vigano, J. Routy, G. Sebastiani, 2022, Biomedicines.

Explaining the Presence of “Heterosexual” Female Clients of a Rapid HIV Testing Site Located in the Gay Village of Montreal, Quebec

Réjean Thomas, B. Lebouché, K. Engler, 2016, Journal of primary care & community health.

Potential interventions to support HCV treatment uptake among HIV co-infected people in Canada: Perceptions of patients and health care providers

M. Klein, B. Lebouché, K. Engler, 2021, Canadian liver journal.

Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis.

M. Klein, B. Lebouché, K. Engler, 2021, The International journal on drug policy.

Symptomatic relapse of neurologic syphilis after benzathine penicillin G therapy for primary or secondary syphilis in HIV-infected patients.

L. Cotte, C. Trépo, B. Lebouché, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Barriers to health-care and psychological distress among mothers living with HIV in Quebec (Canada)

M. Blais, N. Lapointe, Mylène Fernet, 2015, AIDS care.

Barriers and Facilitators Affecting the HIV Care Cascade for Migrant People Living with HIV in Organization for Economic Co-Operation and Development Countries: A Systematic Mixed Studies Review

I. Vedel, K. Mate, J. Cox, 2021, AIDS patient care and STDs.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Evaluation of a Rapid Point of Care Test for Detecting Acute and Established HIV Infection, and Examining the Role of Study Quality on Diagnostic Accuracy: A Bayesian Meta-Analysis

L. Joseph, B. Lebouché, R. Vijh, 2016, PloS one.

Reevaluating Canada’s policy for blood donations from men who have sex with men (MSM)

B. Lebouché, J. Cygler, B. Jubran, 2016, Journal of public health policy.

Reevaluating Canada’s policy for blood donations from men who have sex with men (MSM)

B. Lebouché, J. Cygler, B. Jubran, 2016, Journal of Public Health Policy.

Increased reengagement of out-of-care HIV patients using Lost & Found, a clinic-based intervention

J. Cox, B. Lebouché, Blake Linthwaite, 2021, AIDS.

Social capital and HIV-serodiscordance: Disparities in access to personal and professional resources for HIV-positive and HIV-negative partners

A. Burchell, J. Iveniuk, J. Mendelsohn, 2022, SSM - population health.

Understanding the Risks and Benefits of a Patient Portal Configured for HIV Care: Patient and Healthcare Professional Perspectives

J. Routy, K. Lacombe, N. Sheehan, 2022, Journal of personalized medicine.

A Review of HIV-Specific Patient-Reported Outcome Measures

B. Lebouché, K. Engler, D. Lessard, 2017, The Patient - Patient-Centered Outcomes Research.

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts

J. Routy, J. Bruneau, B. Lebouché, 2016, PloS one.

Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects

C. Tremblay, J. Routy, M. Pazgier, 2019, mBio.

Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis

Lisa P. Barrett, I. Bogoch, C. Tremblay, 2017, Canadian Medical Association Journal.

Predictors of interest in taking pre‐exposure prophylaxis among men who have sex with men who used a rapid HIV‐testing site in Montreal (Actuel sur Rue)

B. Lebouché, K. Engler, D. Lessard, 2016, HIV medicine.

An analysis of socio-demographic and behavioural factors among immigrant MSM in Montreal from an HIV-testing site sample

Réjean Thomas, B. Lebouché, K. Engler, 2016 .

Explaining the appeal for immigrant men who have sex with men of a community-based rapid HIV-testing site in Montreal (Actuel sur Rue)

Réjean Thomas, B. Lebouché, K. Engler, 2015, AIDS care.

“Live a normal life”: Constructions of resilience among people in mixed HIV status relationships in Canada

J. Mendelsohn, A. Daftary, B. Lebouché, 2023, PloS one.

Delayed linkage to HIV care among asylum seekers in Quebec, Canada

C. Frenette, N. Sheehan, J. Cox, 2019, BMC Public Health.

Reasons for COVID-19 vaccine refusal among people incarcerated in Canadian federal prisons

N. Basta, S. MacDonald, J. Cox, 2022, PloS one.

Implementation of Lost & Found, An Intervention to Reengage Patients Out of HIV Care: A Convergent Explanatory Sequential Mixed-Methods Analysis

B. Lebouché, Blake Linthwaite, K. Engler, 2022, AIDS and Behavior.

Remote Follow-up of Self-isolating COVID-19 Patients with a Patient Portal: Protocol for a Mixed-method Pilot Study (The Opal-COVID Study) (Preprint)

M. Brouillette, S. Bartlett, S. Barkati, 2021 .

Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross‐sectional study

J. Bourbeau, J. Routy, J. Bourbeau, 2019, HIV medicine.

Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028—study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation

J. Singer, J. Routy, M. Brouillette, 2019, BMJ Open.

Content validation of a new measure of patient-reported barriers to antiretroviral therapy adherence, the I-Score: results from a Delphi study

K. Mate, Sara Ahmed, B. Lebouché, 2022, Journal of Patient-Reported Outcomes.

COVID-19 vaccine immunogenicity in people with HIV

A. Burchell, M. Ostrowski, C. Kovacs, 2022, AIDS.

Barriers to Use of Remote Monitoring Technologies Used to Support Patients With COVID-19: Rapid Review

K. Mate, M. Pomey, J. Cox, 2021, JMIR mHealth and uHealth.

Barriers to Use of Remote Monitoring Technologies Used to Support Patients With COVID-19: Rapid Review (Preprint)

K. Mate, M. Pomey, B. Lebouché, 2020 .

Family quality of life in families affected by HIV: the perspective of HIV-positive mothers

M. Blais, N. Lapointe, Mylène Fernet, 2014, AIDS care.

Decision-making about motherhood among women living with HIV in Canada: a negotiation of multidimensional risks

Mylène Fernet, B. Lebouché, J. Otis, 2018, Culture, health & sexuality.

Healthcare Professional Perspectives on the Use of Remote Patient-Monitoring Platforms during the COVID-19 Pandemic: A Cross-Sectional Study

M. Pomey, B. Lebouché, M. Desrosiers, 2022, Journal of personalized medicine.

Remote Patient Monitoring Program for COVID-19 Patients Following Hospital Discharge: A Cross-Sectional Study

M. Pomey, B. Lebouché, M. Desrosiers, 2021, Frontiers in Digital Health.

Evaluation of a project to engage patients in the development of a patient‐reported measure for HIV care (the I‐Score Study)

J. Routy, B. Lebouché, K. Engler, 2018, Health expectations : an international journal of public participation in health care and health policy.

Utility of mobile technology in medical interpretation: A literature review of current practices.

K. Mate, B. Lebouché, Kenzy Abdelhamid, 2021, Patient Education and Counseling.

Non-alcoholic fatty liver disease predicts development of metabolic comorbidities in HIV-infected patients.

G. Sebastiani, G. Guaraldi, T. Krahn, 2020, The Journal of infectious diseases.

Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection

G. Sebastiani, P. Ghali, J. Cox, 2018, PloS one.

The linkage-to-care, early retention, and description of HIV-positive clients at a rapid HIV-testing site in Montreal, Canada (Actuel sur Rue)

Réjean Thomas, B. Lebouché, K. Engler, 2017 .

Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286)

S. Trottier, V. Martel-Laferrière, B. Conway, 2022, Patient preference and adherence.

Prognostic value of non‐invasive scores based on liver stiffness measurement, spleen diameter and platelets in HIV‐infected patients

J. Rockstroh, J. Milic, G. Sebastiani, 2023, Liver international : official journal of the International Association for the Study of the Liver.

The involvement of people living with HIV in the development of HIV-specific or inclusive health instruments: a mixed methods review

Charo Rodríguez, B. Lebouché, K. Engler, 2020, AIDS care.

Engaging stakeholders into an electronic patient-reported outcome development study: On making an HIV-specific e-PRO patient-centered

B. Lebouché, K. Engler, D. Lessard, 2017 .

French HIV Experts on Early Antiretroviral Treatment for Prevention

J. Routy, W. Rozenbaum, B. Spire, 2014, Journal of the International Association of Providers of AIDS Care.

The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy – CTN PT006: study protocol for a randomized controlled trial

J. Singer, J. Routy, M. Brouillette, 2014, Trials.

Incidence rate and risk factors for loss to follow‐up in a French clinical cohort of HIV‐infected patients from January 1985 to January 1998

Y. Yazdanpanah, B. Lebouché, D. Sissoko, 2006, HIV medicine.

Acceptability of a Patient Portal (Opal) in HIV Clinical Care: A Feasibility Study

T. Schuster, J. Routy, J. Kildea, 2021, Journal of personalized medicine.

Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial

J. Routy, G. Sebastiani, N. Chomont, 2023, Cells.

Camu Camu effects on microbial translocation and systemic immune activation in ART-treated people living with HIV: protocol of the single-arm non-randomised Camu Camu prebiotic pilot study (CIHR/CTN PT032)

J. Routy, A. Marette, S. Isnard, 2022, BMJ Open.

B. Lebouché, K. Engler, D. Lessard, 2018 .

Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study

C. Tremblay, J. Routy, Réjean Thomas, 2023, BMJ Open.

Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study

M. Maheu-Giroux, J. Cox, M. Klein, 2023, International Journal of Drug Policy.

Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort

J. Routy, G. Sebastiani, S. Walmsley, 2023, BMJ open.

Acceptability of a digital patient notification and linkage-to-care tool for French PrEPers (WeFLASH©): Key stakeholders' perspectives

B. Lebouché, D. Lessard, S. Morel, 2019, International journal of STD & AIDS.

Remote Follow-up of Self-isolating Patients With COVID-19 Using a Patient Portal: Protocol for a Mixed Methods Pilot Study (Opal-COVID Study)

M. Brouillette, S. Bartlett, S. Barkati, 2021, JMIR research protocols.

Developing a patient-reported outcome measure for HIV care on perceived barriers to antiretroviral adherence: assessing the needs of HIV clinicians through qualitative analysis

F. Raffi, B. Spire, L. Wong, 2018, Quality of Life Research.

Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.

M. Sewitch, G. Sebastiani, P. Ghali, 2017, Journal of hepatology.

M. Chevallier, F. Zoulim, P. Pradat, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fibroscan-aspartate aminotransferase (FAST) score predicts liver-related outcomes, but not extra-hepatic events, in a multicenter cohort of people with HIV.

J. Milic, G. Sebastiani, G. Guaraldi, 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Roles, Users, Benefits, and Limitations of Chatbots in Health Care: Rapid Review

B. Lebouché, K. Engler, D. Lessard, 2024, Journal of medical Internet research.

Ongoing impact of the social determinants of health during the second and third waves of the COVID-19 pandemic in People Living with HIV receiving care in a Montreal-based Tertiary Care Centre.

J. Routy, C. Costiniuk, C. Frenette, 2022, AIDS research and human retroviruses.

Patient‐reported outcome measures in adult HIV care: A rapid scoping review of targeted outcomes and instruments used

B. Lebouché, K. Engler, A. Cadri, 2024, HIV Medicine.